Androgen production in pediatric adrenocortical tumors may occur via both the classic and/or the alternative backdoor pathway
Language English Country Ireland Media print-electronic
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
28501574
DOI
10.1016/j.mce.2017.05.014
PII: S0303-7207(17)30272-1
Knihovny.cz E-resources
- Keywords
- Alternative (backdoor) pathway, Androgen biosynthesis, Classic pathway, Dihydrotestosterone, Pediatric adrenocortical tumors,
- MeSH
- Adrenocortical Carcinoma metabolism pathology MeSH
- Adrenal Cortex Neoplasms metabolism pathology MeSH
- Androgens biosynthesis blood MeSH
- Dihydrotestosterone blood MeSH
- Child MeSH
- Immunohistochemistry MeSH
- Infant MeSH
- Humans MeSH
- Li-Fraumeni Syndrome genetics MeSH
- Adolescent MeSH
- Tumor Suppressor Protein p53 genetics MeSH
- Ovarian Neoplasms metabolism pathology MeSH
- Virilism metabolism pathology MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Androgens MeSH
- Dihydrotestosterone MeSH
- Tumor Suppressor Protein p53 MeSH
- TP53 protein, human MeSH Browser
Children with adrenocortical tumors (ACTs) often present with virilization due to high tumoral androgen production, with dihydrotestosterone (DHT) as most potent androgen. Recent work revealed two pathways for DHT biosynthesis, the classic and the backdoor pathway. Usage of alternate routes for DHT production has been reported in castration-resistant prostate cancer, CAH and PCOS. To assess whether the backdoor pathway may contribute to the virilization of pediatric ACTs, we investigated seven children suffering from androgen producing tumors using steroid profiling and immunohistochemical expression studies. All cases produced large amounts of androgens of the classic and/or backdoor pathway. Variable expression of steroid enzymes was observed in carcinomas and adenomas. We found no discriminative pattern. This suggests that enhanced androgen production in pediatric ACTs is the result of deregulated steroidogenesis through multiple steroid pathways. Thus future treatments of ACTs targeting androgen overproduction should consider these novel steroid production pathways.
Institute of Pathology University of Bern Switzerland
Pediatric Endocrinology and Diabetology Department of Pediatrics Switzerland
References provided by Crossref.org